TY - JOUR A1 - Rätsch, Gunnar A1 - Schölkopf, B. A1 - Smola, Alexander J. A1 - Mika, Sebastian A1 - Onoda, T. A1 - Müller, Klaus-Robert T1 - Robust ensemble learning for data analysis Y1 - 2000 ER - TY - JOUR A1 - Mika, Sebastian A1 - Rätsch, Gunnar A1 - Weston, J. A1 - Schölkopf, B. A1 - Smola, Alexander J. A1 - Müller, Klaus-Robert T1 - Invariant feature extraction and classification in kernel spaces Y1 - 2000 ER - TY - BOOK A1 - Rätsch, Gunnar A1 - Schölkopf, B. A1 - Mika, Sebastian A1 - Müller, Klaus-Robert T1 - SVM and boosting : one class T3 - GMD-Report Y1 - 2000 VL - 119 PB - GMD-Forschungszentrum Informationstechnik CY - Sankt Augustin ER - TY - JOUR A1 - Rätsch, Gunnar A1 - Schölkopf, B. A1 - Smola, Alexander J. A1 - Müller, Klaus-Robert A1 - Mika, Sebastian T1 - V-Arc : ensemble learning in the preence of outliers Y1 - 2000 ER - TY - JOUR A1 - Rätsch, Gunnar A1 - Schölkopf, B. A1 - Smola, Alexander J. A1 - Mika, Sebastian A1 - Onoda, T. A1 - Müller, Klaus-Robert T1 - Robust ensemble learning Y1 - 2000 SN - 0-262-19448-1 ER - TY - JOUR A1 - Zien, Alexander A1 - Rätsch, Gunnar A1 - Mika, Sebastian A1 - Schölkopf, Bernhard A1 - Lengauer, Thomas A1 - Müller, Klaus-Robert T1 - Engineering support vector machine kernels that recognize translation initiation sites Y1 - 2000 SN - 1367-4803 ER - TY - JOUR A1 - Muller, K. R. A1 - Ratsch, G. A1 - Sonnenburg, S. A1 - Mika, Sebastian A1 - Grimm, M. A1 - Heinrich, N. T1 - Classifying 'drug-likeness' with kernel-based learning methods N2 - In this article we report about a successful application of modern machine learning technology, namely Support Vector Machines, to the problem of assessing the 'drug-likeness' of a chemical from a given set of descriptors of the Substance. We were able to drastically improve the recent result by Byvatov et al. (2003) on this task and achieved an error rate of about 7% on unseen compounds using Support Vector Machines. We see a very high potential of such machine learning techniques for a variety of computational chemistry problems that occur in the drug discovery and drug design process Y1 - 2005 SN - 1549-9596 ER -